Differential Effect of Hospitalization on Cystatin C– and Creatinine-Based Estimated GFR
Authors:
- Ian E. McCoyIMIan E. McCoy
- Alan S. GoAGAlan S. Go
- Jesse Y. HsuJHJesse Y. Hsu
- Xiaoming ZhangXZXiaoming Zhang
- Vallabh O. ShahVSVallabh O. Shah
- Matthew WeirMWMatthew Weir
- Hernan Rincon-CholesHRHernan Rincon-Choles
- Debbie L. CohenDCDebbie L. Cohen
- Amanda AndersonAAAmanda Anderson
- Bernard JaarBJBernard Jaar
- James SondheimerJSJames Sondheimer
- 11 March 2025
- journal article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 36 (8) , 1585-1591
Abstract
Key Points: Critical illness is known to acutely decrease eGFRdiff (estimation of GFR by cystatin C−estimation of GFR from serum creatinine [eGFRCr]), presumably because of loss of muscle mass falsely elevating eGFRCr. It is unknown whether this eGFRdiff effect occurs in all-cause hospitalizations and whether the effect persists after hospitalization. More hospitalization was associated with larger decreases in estimation of GFR by cystatin C compared with eGFRCr on measurements months after hospital discharge. Background: Cystatin C has entered mainstream clinical care as a measure of kidney function, joining serum creatinine, which has been used for almost a century. However, many physicians notice that estimation of GFR from serum creatinine (eGFRCr) and estimation of GFR by cystatin C (eGFRCys) values can differ considerably. Hospitalization with critical illness is known to acutely decrease eGFRdiff (eGFRCys−eGFRCr). However, whether this effect occurs in all-cause hospitalizations and persists after hospitalization is unknown. Methods: Among 5599 adult participants in the Chronic Renal Insufficiency Cohort study with serum creatinine and cystatin C measurements, we estimated the association of six categories of total days of hospitalization between annual study visits (never hospitalized, hospitalized e.g ., −3.30 [95% confidence interval, −5.48 to −1.13] ml/min per 1.73 m 2 for ≥42 days of hospitalization, test for trend P < 0.001), while eGFRCr remained relatively stable ( e.g ., −1.12 [−2.77 to 0.53] ml/min per 1.73 m 2 for ≥42 days of hospitalization, test for trend P = 0.21). The differential effect resulted in eGFRdiff becoming progressively more negative with more total days of hospitalization (test for trend P < 0.001). Conclusions: Prolonged or repeated hospitalization was associated with larger decreases in eGFRCys compared with eGFRCr on measurements months after hospital discharge.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (K23DK128605)
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK92291)
This publication has 23 references indexed in Scilit:
- Discordances Between Creatinine- and Cystatin C–Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical PracticeAmerican Journal of Kidney Diseases, 2023
- The Difference Between Cystatin C– and Creatinine-Based Estimated GFR in Heart Failure With Reduced Ejection Fraction: Insights From PARADIGM-HFAmerican Journal of Kidney Diseases, 2023
- Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart FailureAmerican Journal of Kidney Diseases, 2022
- The Difference Between Cystatin C- and Creatinine-Based Assessment of Kidney Function in Acute Heart FailureESC Heart Failure, 2022
- Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and MortalityJAMA Network Open, 2022
- Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report From the NKF-ASN Task ForceAmerican Journal of Kidney Diseases, 2021
- Utility of Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) Equations in Obese Diabetic Individuals Before and After Weight LossAmerican Journal of Kidney Diseases, 2014
- SCr and SCysC Concentrations Before and After Traumatic Amputation in Male Soldiers: A Case-Control StudyAmerican Journal of Kidney Diseases, 2014
- Update on Cystatin C: Incorporation Into Clinical PracticeAmerican Journal of Kidney Diseases, 2013
- Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rateKidney International, 2011